An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (GERTAC)
Clinical trial NCT01790217 · COMPLETED
Trial details
- NCT number
- NCT01790217
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-07-01
- Primary completion
- 2013-08-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.